GSK Profit Beats Estimates on HIV, Cancer Medicines

GSK Plc’s profit was higher than analysts expected in the first quarter, helped by the drugmaker’s specialty medicines for HIV, cancer and immune diseases.

Source

Bloomberg Markets

Read full article at Bloomberg Markets

Opens original article in a new tab

Trump threatens Iran with AI picture of himself with a gun: 'No more Mr. Nice guy!'

Oil prices continued to rise on Wednesday after U.S. President Donald Trump appeared to threaten Iran in a TruthSocial post.

about 1 hour agoRead more →

EconomyDaily Composite

CNBC

Treasury yields little changed as investors await Fed decision

The yield on the 10-year U.S. Treasury note — the key benchmark for U.S. government borrowing — was broadly unchanged at 4.358%.

about 1 hour agoRead more →

EconomyDaily Composite

Bloomberg Markets

The China Show 4/29/2026 (Video)

about 1 hour agoRead more →

Bloomberg Markets

Neuberger Space Fund Turns to Europe as SpaceX Hype Buoys Sector

Evelyn Chow’s space-focused stock fund is scouring Europe for bargains just as the looming debut of SpaceX supercharges valuations in the US.

about 1 hour agoRead more →

Related Economy Stories

Trump threatens Iran with AI picture of himself with a gun: 'No more Mr. Nice guy!'

Treasury yields little changed as investors await Fed decision

The China Show 4/29/2026 (Video)

Neuberger Space Fund Turns to Europe as SpaceX Hype Buoys Sector